Paul Drew
Concepts (368)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ethanol | 15 | 2024 | 338 | 6.360 |
Why?
| Microglia | 28 | 2024 | 141 | 5.530 |
Why?
| Astrocytes | 10 | 2021 | 145 | 2.560 |
Why?
| Cerebellum | 8 | 2024 | 133 | 2.290 |
Why?
| Alcoholism | 4 | 2023 | 232 | 2.240 |
Why?
| Hippocampus | 9 | 2022 | 228 | 2.020 |
Why?
| Multiple Sclerosis | 10 | 2021 | 65 | 1.860 |
Why?
| Central Nervous System | 5 | 2020 | 85 | 1.800 |
Why?
| Animals | 62 | 2024 | 13150 | 1.610 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 10 | 2014 | 20 | 1.600 |
Why?
| Mice | 36 | 2024 | 5720 | 1.430 |
Why?
| Mice, Inbred C57BL | 24 | 2023 | 1806 | 1.420 |
Why?
| PPAR gamma | 6 | 2017 | 73 | 1.330 |
Why?
| Animals, Newborn | 10 | 2021 | 366 | 1.220 |
Why?
| Prostaglandin D2 | 8 | 2011 | 21 | 1.220 |
Why?
| Inflammasomes | 3 | 2024 | 58 | 1.200 |
Why?
| Cytokines | 19 | 2021 | 612 | 1.200 |
Why?
| Receptors, Cytoplasmic and Nuclear | 9 | 2009 | 64 | 1.100 |
Why?
| Thiazolidinediones | 5 | 2017 | 82 | 1.030 |
Why?
| Nitric Oxide | 14 | 2012 | 253 | 1.020 |
Why?
| Disease Models, Animal | 10 | 2024 | 1451 | 0.990 |
Why?
| Neurogenesis | 2 | 2021 | 27 | 0.970 |
Why?
| Transcription Factors | 13 | 2004 | 563 | 0.970 |
Why?
| DNA-Binding Proteins | 7 | 2009 | 436 | 0.950 |
Why?
| PPAR alpha | 5 | 2009 | 58 | 0.920 |
Why?
| Brain | 8 | 2013 | 1309 | 0.900 |
Why?
| Neuroimmunomodulation | 2 | 2014 | 14 | 0.890 |
Why?
| Immunity | 2 | 2013 | 36 | 0.890 |
Why?
| Central Nervous System Depressants | 2 | 2013 | 79 | 0.870 |
Why?
| Retinoid X Receptors | 5 | 2006 | 13 | 0.850 |
Why?
| Transcriptome | 2 | 2023 | 313 | 0.840 |
Why?
| Cells, Cultured | 21 | 2017 | 1571 | 0.820 |
Why?
| Gene Expression Regulation | 13 | 2017 | 979 | 0.820 |
Why?
| RNA, Messenger | 15 | 2021 | 1105 | 0.800 |
Why?
| Pregnancy | 10 | 2024 | 2584 | 0.790 |
Why?
| Interleukin-12 | 3 | 2007 | 31 | 0.780 |
Why?
| Neurons | 8 | 2017 | 459 | 0.750 |
Why?
| Zinc Fingers | 5 | 1997 | 23 | 0.730 |
Why?
| Cerebral Cortex | 9 | 2021 | 200 | 0.700 |
Why?
| Immunity, Cellular | 3 | 2015 | 69 | 0.680 |
Why?
| Tretinoin | 5 | 2005 | 53 | 0.650 |
Why?
| Cell Survival | 11 | 2012 | 598 | 0.630 |
Why?
| Aging | 2 | 2013 | 688 | 0.620 |
Why?
| Neuroglia | 4 | 2007 | 43 | 0.620 |
Why?
| Anti-Inflammatory Agents | 3 | 2020 | 162 | 0.610 |
Why?
| T-Lymphocytes, Helper-Inducer | 3 | 2017 | 42 | 0.610 |
Why?
| Encephalomyelitis | 2 | 2017 | 6 | 0.600 |
Why?
| Inflammation | 7 | 2012 | 604 | 0.560 |
Why?
| Alcoholic Neuropathy | 1 | 2016 | 2 | 0.560 |
Why?
| Enzyme-Linked Immunosorbent Assay | 11 | 2012 | 245 | 0.560 |
Why?
| DNA, Complementary | 8 | 2013 | 135 | 0.540 |
Why?
| Autoimmunity | 3 | 2011 | 35 | 0.520 |
Why?
| Lipopolysaccharides | 11 | 2012 | 191 | 0.510 |
Why?
| Tumor Necrosis Factor-alpha | 9 | 2013 | 388 | 0.490 |
Why?
| RNA | 4 | 2023 | 170 | 0.490 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2012 | 121 | 0.480 |
Why?
| Encephalitis | 2 | 2006 | 41 | 0.450 |
Why?
| Analysis of Variance | 7 | 2012 | 565 | 0.450 |
Why?
| Drug Interactions | 7 | 2012 | 206 | 0.440 |
Why?
| Dose-Response Relationship, Drug | 11 | 2014 | 1374 | 0.440 |
Why?
| Naphthoquinones | 1 | 2012 | 10 | 0.430 |
Why?
| Mitoxantrone | 1 | 2012 | 9 | 0.430 |
Why?
| 5-Aminolevulinate Synthetase | 5 | 1990 | 5 | 0.410 |
Why?
| Female | 16 | 2024 | 26329 | 0.410 |
Why?
| Nerve Tissue Proteins | 3 | 1997 | 193 | 0.390 |
Why?
| Oligodendroglia | 2 | 2021 | 36 | 0.390 |
Why?
| NF-kappa B | 7 | 2006 | 314 | 0.380 |
Why?
| Interleukin-17 | 2 | 2011 | 36 | 0.360 |
Why?
| Nitric Oxide Synthase | 5 | 2001 | 75 | 0.360 |
Why?
| Toll-Like Receptor 4 | 2 | 2023 | 48 | 0.360 |
Why?
| Peroxisome Proliferator-Activated Receptors | 2 | 2006 | 14 | 0.350 |
Why?
| Fenofibrate | 3 | 2009 | 17 | 0.340 |
Why?
| Chemokine CX3CL1 | 2 | 2021 | 9 | 0.330 |
Why?
| Immune Tolerance | 1 | 2009 | 95 | 0.330 |
Why?
| Toll-Like Receptors | 1 | 2009 | 27 | 0.330 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2021 | 138 | 0.320 |
Why?
| Base Sequence | 13 | 1997 | 650 | 0.310 |
Why?
| Myeloid Differentiation Factor 88 | 2 | 2023 | 33 | 0.300 |
Why?
| Molecular Sequence Data | 13 | 1997 | 797 | 0.300 |
Why?
| Humans | 32 | 2024 | 49827 | 0.300 |
Why?
| Cognition Disorders | 2 | 2021 | 218 | 0.300 |
Why?
| Gene Expression | 5 | 2021 | 608 | 0.290 |
Why?
| Genes, MHC Class I | 4 | 1995 | 11 | 0.280 |
Why?
| Gliosis | 1 | 2006 | 6 | 0.280 |
Why?
| beta 2-Microglobulin | 3 | 1995 | 38 | 0.270 |
Why?
| Cyclooxygenase 2 | 1 | 2006 | 45 | 0.270 |
Why?
| Peroxisome Proliferators | 1 | 2005 | 7 | 0.260 |
Why?
| Prostaglandins A | 1 | 2005 | 2 | 0.260 |
Why?
| Chemokines | 4 | 2006 | 77 | 0.260 |
Why?
| Chemokine CCL2 | 3 | 2013 | 71 | 0.250 |
Why?
| Esophageal Neoplasms | 1 | 2006 | 99 | 0.240 |
Why?
| Apoptosis | 2 | 2021 | 1100 | 0.240 |
Why?
| Male | 8 | 2024 | 25093 | 0.240 |
Why?
| Sulfonamides | 3 | 2011 | 129 | 0.230 |
Why?
| Hemin | 3 | 1989 | 8 | 0.230 |
Why?
| Heme | 3 | 1989 | 21 | 0.230 |
Why?
| Nitric Oxide Synthase Type II | 5 | 2008 | 66 | 0.230 |
Why?
| Gonadal Steroid Hormones | 1 | 2003 | 42 | 0.230 |
Why?
| Myelin-Oligodendrocyte Glycoprotein | 3 | 2014 | 8 | 0.220 |
Why?
| Cytokine-Induced Killer Cells | 1 | 2023 | 2 | 0.220 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 43 | 0.220 |
Why?
| Central Nervous System Diseases | 1 | 2003 | 27 | 0.210 |
Why?
| Carcinoma, Squamous Cell | 1 | 2006 | 319 | 0.210 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 181 | 0.210 |
Why?
| Allylisopropylacetamide | 4 | 1990 | 4 | 0.210 |
Why?
| Chromosome Mapping | 3 | 1997 | 160 | 0.210 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 193 | 0.210 |
Why?
| Interferon-gamma | 5 | 2005 | 174 | 0.210 |
Why?
| T-Lymphocytes | 3 | 2007 | 338 | 0.200 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2014 | 163 | 0.200 |
Why?
| Myelin Sheath | 1 | 2021 | 28 | 0.200 |
Why?
| Interneurons | 1 | 2021 | 31 | 0.190 |
Why?
| Amino Acid Sequence | 6 | 1997 | 587 | 0.190 |
Why?
| Estriol | 1 | 2000 | 4 | 0.190 |
Why?
| Dehydroepiandrosterone | 1 | 2000 | 15 | 0.190 |
Why?
| Progesterone | 1 | 2000 | 57 | 0.190 |
Why?
| Chronic Disease | 1 | 2023 | 563 | 0.180 |
Why?
| Interleukins | 3 | 2011 | 32 | 0.180 |
Why?
| Polysaccharides | 2 | 2012 | 50 | 0.180 |
Why?
| Cell Cycle | 1 | 2021 | 232 | 0.180 |
Why?
| Hydrocortisone | 1 | 2000 | 107 | 0.180 |
Why?
| Colorectal Neoplasms | 1 | 2023 | 234 | 0.180 |
Why?
| Acetamides | 2 | 1990 | 20 | 0.170 |
Why?
| Immunohistochemistry | 4 | 2013 | 971 | 0.170 |
Why?
| Estradiol | 1 | 2000 | 225 | 0.170 |
Why?
| Histocompatibility Antigens Class I | 2 | 1995 | 44 | 0.160 |
Why?
| Mice, Transgenic | 6 | 2017 | 555 | 0.160 |
Why?
| Hydroxycholesterols | 1 | 1998 | 9 | 0.160 |
Why?
| beta-Cyclodextrins | 1 | 1998 | 16 | 0.160 |
Why?
| Thiazoles | 2 | 2011 | 51 | 0.160 |
Why?
| Orphan Nuclear Receptors | 2 | 2009 | 15 | 0.160 |
Why?
| Hydrocarbons, Fluorinated | 2 | 2009 | 8 | 0.160 |
Why?
| HTLV-I Infections | 1 | 1997 | 3 | 0.150 |
Why?
| Human T-lymphotropic virus 1 | 1 | 1997 | 3 | 0.150 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 1997 | 3 | 0.150 |
Why?
| Genes | 1 | 1997 | 34 | 0.150 |
Why?
| Gene Expression Regulation, Viral | 1 | 1997 | 48 | 0.150 |
Why?
| Peptide Fragments | 4 | 2014 | 216 | 0.150 |
Why?
| Receptors, CCR6 | 1 | 2017 | 3 | 0.150 |
Why?
| Liver | 3 | 1989 | 1109 | 0.150 |
Why?
| Tumor Cells, Cultured | 7 | 2001 | 465 | 0.150 |
Why?
| Conserved Sequence | 2 | 1997 | 56 | 0.150 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 1997 | 8 | 0.150 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 1997 | 29 | 0.150 |
Why?
| Antineoplastic Agents | 1 | 2005 | 1172 | 0.150 |
Why?
| Protein Structure, Tertiary | 1 | 1997 | 253 | 0.140 |
Why?
| Alzheimer Disease | 1 | 2000 | 317 | 0.140 |
Why?
| Receptors, HIV | 1 | 2016 | 2 | 0.140 |
Why?
| Receptors, Cytokine | 1 | 2016 | 11 | 0.140 |
Why?
| Freund's Adjuvant | 2 | 2014 | 8 | 0.140 |
Why?
| Transcription, Genetic | 3 | 2009 | 371 | 0.140 |
Why?
| Sequence Homology, Amino Acid | 4 | 1997 | 146 | 0.130 |
Why?
| Consensus Sequence | 1 | 1995 | 24 | 0.130 |
Why?
| Neuroprotective Agents | 1 | 2017 | 105 | 0.130 |
Why?
| Blotting, Western | 4 | 2009 | 602 | 0.130 |
Why?
| Behavior, Animal | 1 | 2017 | 182 | 0.130 |
Why?
| Acromegaly | 1 | 2015 | 7 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 1997 | 323 | 0.130 |
Why?
| Promoter Regions, Genetic | 6 | 2009 | 477 | 0.130 |
Why?
| Phosphoproteins | 1 | 1995 | 113 | 0.130 |
Why?
| Cellular Microenvironment | 1 | 2015 | 26 | 0.130 |
Why?
| Rats | 5 | 2001 | 3300 | 0.130 |
Why?
| Th17 Cells | 2 | 2014 | 26 | 0.130 |
Why?
| Adipose Tissue, White | 1 | 2015 | 34 | 0.120 |
Why?
| Growth Hormone | 1 | 2015 | 96 | 0.120 |
Why?
| Ethylenes | 1 | 2014 | 7 | 0.120 |
Why?
| Repressor Proteins | 1 | 1995 | 151 | 0.120 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2016 | 181 | 0.120 |
Why?
| Interleukin-6 | 2 | 2013 | 264 | 0.120 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2013 | 30 | 0.110 |
Why?
| Interleukin-23 | 2 | 2012 | 8 | 0.110 |
Why?
| Spleen | 2 | 2012 | 173 | 0.110 |
Why?
| Genes, Regulator | 1 | 1993 | 4 | 0.110 |
Why?
| Dihydropyridines | 2 | 1990 | 8 | 0.110 |
Why?
| Testosterone | 3 | 1990 | 139 | 0.110 |
Why?
| Age Factors | 1 | 2016 | 1090 | 0.110 |
Why?
| Immunologic Factors | 2 | 2014 | 114 | 0.110 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 73 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 197 | 0.100 |
Why?
| Cloning, Molecular | 3 | 1997 | 189 | 0.100 |
Why?
| Fetus | 2 | 2012 | 217 | 0.100 |
Why?
| Stilbenes | 1 | 2012 | 62 | 0.100 |
Why?
| Chick Embryo | 5 | 1990 | 83 | 0.100 |
Why?
| Mental Disorders | 1 | 2016 | 389 | 0.100 |
Why?
| Bone Marrow Cells | 1 | 2012 | 192 | 0.100 |
Why?
| Gemfibrozil | 2 | 2009 | 9 | 0.100 |
Why?
| Dendritic Cells | 1 | 2012 | 132 | 0.100 |
Why?
| Severity of Illness Index | 2 | 2012 | 942 | 0.100 |
Why?
| Neurodegenerative Diseases | 1 | 2012 | 76 | 0.100 |
Why?
| DNA | 4 | 2006 | 545 | 0.100 |
Why?
| Cell Count | 1 | 2011 | 146 | 0.090 |
Why?
| Receptors, Retinoic Acid | 2 | 2004 | 23 | 0.090 |
Why?
| Myelin Proteins | 1 | 2009 | 4 | 0.090 |
Why?
| Receptors, Interleukin | 1 | 2009 | 10 | 0.090 |
Why?
| Myelin-Associated Glycoprotein | 1 | 2009 | 8 | 0.090 |
Why?
| Time Factors | 3 | 2012 | 2912 | 0.090 |
Why?
| Isoenzymes | 1 | 1989 | 168 | 0.080 |
Why?
| Inflammation Mediators | 2 | 2007 | 112 | 0.080 |
Why?
| Infant, Newborn | 1 | 2016 | 2744 | 0.080 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 1990 | 195 | 0.080 |
Why?
| Cell Line | 4 | 2017 | 1002 | 0.080 |
Why?
| Brain Abscess | 1 | 2008 | 12 | 0.080 |
Why?
| Cell Differentiation | 1 | 2011 | 653 | 0.080 |
Why?
| Cell Proliferation | 2 | 2014 | 1007 | 0.080 |
Why?
| Immunosuppressive Agents | 1 | 2009 | 220 | 0.080 |
Why?
| Blotting, Northern | 3 | 1995 | 109 | 0.080 |
Why?
| Tissue Distribution | 3 | 1995 | 164 | 0.070 |
Why?
| Antigen-Presenting Cells | 1 | 2007 | 26 | 0.070 |
Why?
| Nitroprusside | 1 | 2006 | 10 | 0.070 |
Why?
| Irritable Bowel Syndrome | 1 | 2007 | 17 | 0.070 |
Why?
| Drug Synergism | 2 | 1998 | 150 | 0.070 |
Why?
| Adult | 3 | 2024 | 13160 | 0.070 |
Why?
| Lymph Nodes | 2 | 2006 | 264 | 0.070 |
Why?
| Leukocytes, Mononuclear | 1 | 2007 | 116 | 0.070 |
Why?
| Brain Neoplasms | 2 | 2001 | 286 | 0.070 |
Why?
| Epithelium | 1 | 2006 | 65 | 0.070 |
Why?
| Tetrazolium Salts | 1 | 2005 | 13 | 0.070 |
Why?
| Interferon-alpha | 1 | 2005 | 47 | 0.070 |
Why?
| Transfection | 4 | 2009 | 357 | 0.060 |
Why?
| Esophagectomy | 1 | 2006 | 36 | 0.060 |
Why?
| Esophagus | 1 | 2006 | 84 | 0.060 |
Why?
| Inhibitory Concentration 50 | 1 | 2005 | 76 | 0.060 |
Why?
| Staphylococcal Infections | 1 | 2008 | 269 | 0.060 |
Why?
| Staphylococcus aureus | 2 | 2008 | 326 | 0.060 |
Why?
| Autoimmune Diseases | 1 | 2006 | 100 | 0.060 |
Why?
| Adolescent | 1 | 2016 | 6340 | 0.060 |
Why?
| Lymphatic Metastasis | 1 | 2006 | 230 | 0.060 |
Why?
| Macrophages | 2 | 2008 | 364 | 0.060 |
Why?
| Microbodies | 1 | 2004 | 3 | 0.060 |
Why?
| Neuroblastoma | 2 | 1995 | 52 | 0.060 |
Why?
| Purkinje Cells | 1 | 2024 | 15 | 0.060 |
Why?
| Child | 1 | 2016 | 6824 | 0.060 |
Why?
| Ligands | 3 | 2011 | 204 | 0.060 |
Why?
| Acetic Acid | 1 | 2001 | 12 | 0.050 |
Why?
| Models, Biological | 1 | 2005 | 728 | 0.050 |
Why?
| Immunotherapy, Adoptive | 1 | 2023 | 154 | 0.050 |
Why?
| Neuroimaging | 1 | 2021 | 82 | 0.050 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 63 | 0.050 |
Why?
| Dehydroepiandrosterone Sulfate | 1 | 2000 | 4 | 0.050 |
Why?
| Meningioma | 1 | 2001 | 46 | 0.050 |
Why?
| Protein Biosynthesis | 2 | 2017 | 253 | 0.050 |
Why?
| Nitrites | 1 | 2000 | 30 | 0.050 |
Why?
| Glioma | 1 | 2001 | 79 | 0.050 |
Why?
| Clinical Trials as Topic | 1 | 2023 | 460 | 0.050 |
Why?
| Radiopharmaceuticals | 1 | 2001 | 209 | 0.040 |
Why?
| Neuropsychological Tests | 1 | 2021 | 351 | 0.040 |
Why?
| Cognition | 1 | 2021 | 336 | 0.040 |
Why?
| Polymerase Chain Reaction | 2 | 1997 | 455 | 0.040 |
Why?
| Cyclodextrins | 1 | 1998 | 17 | 0.040 |
Why?
| Spinal Cord | 2 | 2014 | 177 | 0.040 |
Why?
| DNA Fragmentation | 1 | 1998 | 55 | 0.040 |
Why?
| Paraparesis, Tropical Spastic | 1 | 1997 | 1 | 0.040 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 6 | 0.040 |
Why?
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1997 | 6 | 0.040 |
Why?
| Genetic Code | 1 | 1997 | 4 | 0.040 |
Why?
| Drosophila melanogaster | 1 | 1997 | 30 | 0.040 |
Why?
| Mammals | 1 | 1997 | 56 | 0.040 |
Why?
| Kruppel-Like Transcription Factors | 1 | 1997 | 36 | 0.040 |
Why?
| Species Specificity | 1 | 1997 | 193 | 0.040 |
Why?
| RNA Stability | 1 | 2017 | 24 | 0.040 |
Why?
| Autoimmune Diseases of the Nervous System | 1 | 2017 | 9 | 0.040 |
Why?
| 3' Untranslated Regions | 1 | 2017 | 52 | 0.040 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 1997 | 93 | 0.040 |
Why?
| Prospective Studies | 1 | 2023 | 2344 | 0.040 |
Why?
| RNA Interference | 1 | 2017 | 179 | 0.040 |
Why?
| Rats, Sprague-Dawley | 1 | 2000 | 1595 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 1997 | 192 | 0.030 |
Why?
| Rats, Wistar | 1 | 2017 | 223 | 0.030 |
Why?
| Evolution, Molecular | 1 | 1997 | 99 | 0.030 |
Why?
| Cell Movement | 1 | 2017 | 247 | 0.030 |
Why?
| Interferon Regulatory Factor-2 | 1 | 1995 | 3 | 0.030 |
Why?
| Pregnancy Complications | 1 | 2000 | 382 | 0.030 |
Why?
| Interferon Regulatory Factor-1 | 1 | 1995 | 14 | 0.030 |
Why?
| Nuclear Proteins | 1 | 1997 | 243 | 0.030 |
Why?
| Stimulation, Chemical | 1 | 1995 | 28 | 0.030 |
Why?
| Measles virus | 1 | 1995 | 9 | 0.030 |
Why?
| Transcription Factor TFIIIA | 1 | 1995 | 1 | 0.030 |
Why?
| Rana pipiens | 1 | 1995 | 2 | 0.030 |
Why?
| Mumps virus | 1 | 1995 | 12 | 0.030 |
Why?
| Gene Library | 1 | 1995 | 44 | 0.030 |
Why?
| Interferon-beta | 1 | 1995 | 29 | 0.030 |
Why?
| Motor Activity | 1 | 2017 | 230 | 0.030 |
Why?
| Xenopus laevis | 1 | 1995 | 38 | 0.030 |
Why?
| Genetic Vectors | 1 | 1995 | 127 | 0.030 |
Why?
| Stromal Cells | 1 | 2015 | 72 | 0.030 |
Why?
| Oncogene Protein v-akt | 1 | 2014 | 10 | 0.030 |
Why?
| Sequence Analysis, DNA | 1 | 1995 | 237 | 0.030 |
Why?
| HIV-1 | 1 | 1994 | 55 | 0.030 |
Why?
| Mice, Knockout | 1 | 2017 | 841 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2021 | 1533 | 0.030 |
Why?
| Cell Polarity | 1 | 2014 | 16 | 0.030 |
Why?
| Young Adult | 1 | 2024 | 3936 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 41 | 0.030 |
Why?
| Adipose Tissue | 1 | 2015 | 187 | 0.030 |
Why?
| MicroRNAs | 1 | 2017 | 354 | 0.030 |
Why?
| Myelin Basic Protein | 2 | 2004 | 5 | 0.030 |
Why?
| Enhancer Elements, Genetic | 1 | 1993 | 61 | 0.030 |
Why?
| Interleukin-12 Subunit p40 | 1 | 2012 | 2 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 595 | 0.030 |
Why?
| Lymphocyte Activation | 2 | 2004 | 172 | 0.030 |
Why?
| C-Reactive Protein | 1 | 2012 | 142 | 0.020 |
Why?
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2011 | 2 | 0.020 |
Why?
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2011 | 4 | 0.020 |
Why?
| Drug Inverse Agonism | 1 | 2011 | 18 | 0.020 |
Why?
| Retrospective Studies | 1 | 2023 | 6117 | 0.020 |
Why?
| Middle Aged | 1 | 2006 | 11997 | 0.020 |
Why?
| HEK293 Cells | 1 | 2011 | 222 | 0.020 |
Why?
| Aged | 1 | 2024 | 9272 | 0.020 |
Why?
| Enzyme Induction | 1 | 1990 | 80 | 0.020 |
Why?
| Ferrous Compounds | 1 | 1989 | 8 | 0.020 |
Why?
| Models, Molecular | 1 | 2011 | 337 | 0.020 |
Why?
| Aminolevulinic Acid | 1 | 1989 | 8 | 0.020 |
Why?
| RNA Probes | 1 | 1989 | 3 | 0.020 |
Why?
| Enzyme Stability | 1 | 1989 | 20 | 0.020 |
Why?
| Interleukin-5 | 1 | 2009 | 6 | 0.020 |
Why?
| GATA3 Transcription Factor | 1 | 2009 | 5 | 0.020 |
Why?
| Half-Life | 1 | 1989 | 84 | 0.020 |
Why?
| T-Box Domain Proteins | 1 | 2009 | 14 | 0.020 |
Why?
| Interleukin-4 | 1 | 2009 | 43 | 0.020 |
Why?
| Microbial Viability | 1 | 2008 | 30 | 0.020 |
Why?
| Phagocytosis | 1 | 2008 | 48 | 0.020 |
Why?
| Fibronectins | 1 | 2008 | 39 | 0.020 |
Why?
| Proteoglycans | 1 | 2008 | 80 | 0.020 |
Why?
| Cell Wall | 1 | 2008 | 56 | 0.020 |
Why?
| Polyribosomes | 1 | 1987 | 7 | 0.020 |
Why?
| Signal Transduction | 1 | 2014 | 1617 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 1987 | 54 | 0.020 |
Why?
| Dicarbethoxydihydrocollidine | 1 | 1986 | 2 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2007 | 75 | 0.020 |
Why?
| Models, Immunological | 1 | 2006 | 8 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 854 | 0.020 |
Why?
| Psychiatric Status Rating Scales | 1 | 2007 | 319 | 0.020 |
Why?
| Anxiety | 1 | 2007 | 269 | 0.020 |
Why?
| Antigens, Surface | 1 | 2004 | 54 | 0.020 |
Why?
| Th2 Cells | 1 | 2004 | 21 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2004 | 5 | 0.010 |
Why?
| Cell Line, Transformed | 1 | 2004 | 72 | 0.010 |
Why?
| Growth Inhibitors | 1 | 2004 | 27 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 2004 | 38 | 0.010 |
Why?
| Immunization | 1 | 2004 | 67 | 0.010 |
Why?
| Drug Combinations | 1 | 2004 | 123 | 0.010 |
Why?
| Case-Control Studies | 1 | 2007 | 1128 | 0.010 |
Why?
| Cell Nucleus | 2 | 1994 | 184 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 412 | 0.010 |
Why?
| Genes, T-Cell Receptor | 1 | 2002 | 5 | 0.010 |
Why?
| Adoptive Transfer | 1 | 2002 | 39 | 0.010 |
Why?
| Depression | 1 | 2007 | 564 | 0.010 |
Why?
| Flow Cytometry | 1 | 2004 | 470 | 0.010 |
Why?
| Neoplasm Transplantation | 1 | 2001 | 85 | 0.010 |
Why?
| Carbon Radioisotopes | 1 | 2001 | 53 | 0.010 |
Why?
| Biotransformation | 1 | 2001 | 86 | 0.010 |
Why?
| Transplantation, Heterologous | 1 | 2001 | 74 | 0.010 |
Why?
| Radionuclide Imaging | 1 | 2001 | 116 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 626 | 0.010 |
Why?
| Poly I-C | 1 | 1995 | 4 | 0.010 |
Why?
| HIV Long Terminal Repeat | 1 | 1994 | 4 | 0.010 |
Why?
| Oligonucleotide Probes | 1 | 1994 | 17 | 0.010 |
Why?
| NF-kappa B p50 Subunit | 1 | 1994 | 17 | 0.010 |
Why?
| Transcription Factor RelA | 1 | 1994 | 29 | 0.010 |
Why?
| Virus Latency | 1 | 1994 | 47 | 0.010 |
Why?
| Genome, Viral | 1 | 1994 | 79 | 0.010 |
Why?
| Carcinoma, Embryonal | 1 | 1993 | 1 | 0.010 |
Why?
| Embryonal Carcinoma Stem Cells | 1 | 1993 | 2 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1993 | 49 | 0.010 |
Why?
| Up-Regulation | 1 | 1995 | 450 | 0.010 |
Why?
| Binding Sites | 1 | 1994 | 377 | 0.010 |
Why?
| DNA Primers | 1 | 1993 | 206 | 0.010 |
Why?
| Neoplastic Stem Cells | 1 | 1993 | 103 | 0.010 |
Why?
|
|
Drew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|